DIN 02391783 — ARANESP 200 MCG
ARANESP is a solution of Darbepoetin Alfa marketed by AMGEN CANADA INC. The full Darbepoetin Alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02391783
- Brand name
- ARANESP
- Active ingredient
- Darbepoetin Alfa
- Strength
- 200 MCG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Erythropoiesis-stimulating agent (erythropoietin analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Darbepoetin Alfa products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02391740 | ARANESP | 100 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391759 | ARANESP | 100 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02392348 | ARANESP | 100 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391767 | ARANESP | 200 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391775 | ARANESP | 200 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02392356 | ARANESP | 200 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02392313 | ARANESP | 25 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02392321 | ARANESP | 40 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391791 | ARANESP | 500 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391805 | ARANESP | 500 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02391821 | ARANESP | 500 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02392364 | ARANESP | 500 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |